Luke Elias commenced his health career as a physiotherapist and has worked extensively in clinical and health management roles in both the public and private sector in metropolitan and regional acute and primary health care services across NSW. He holds consumer advocate and patient representative roles with national and international organizations with a focus on management of cardiovascular health and rare diseases. He is passionate about supporting highest quality team-based care to meet the needs of vulnerable and priority populations.

Sidney C. Smith, Jr., M.D. is Professor of Medicine at the University of North Carolina in Chapel Hill. Dr Smith received his Medical Doctorate from Yale Medical School and completed his medical internship, residency, and cardiology fellowship at the Brigham Hospital/Harvard Medical School, Boston, MA. Dr Smith is a past president of the American Heart Association (AHA) and has also served as the Chief Science Officer for the AHA. He chaired the ACC/AHA Task Force on Practice Guidelines, the ACC/AHA committee to revise PCI guidelines, the AHA/ACC Guidelines on Secondary Prevention for patients with atherosclerotic vascular disease and served on the ACC/AHA guideline committees for the management of acute myocardial infarction (STEMI), Blood Cholesterol, Risk Prediction, Lifestyle and Hypertension. Dr. Smith was Co-Chair of the ACC/AHA Bethesda Conference on Professionalism and Ethics. Dr. Smith is a Past President of the World Heart Federation (WHF). He served as chair of the WHF Scientific Advisory Board and was Co-Chair of the Scientific Programs for the 2006 World Congress of Cardiology (WCC) in Barcelona, the 2008 WCC in Buenos Aires, the 2010 WCC in Beijing, and the 2012 WCC in Dubai. He served as Chair of the Executive Committee for the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health’s Integrated Guidelines for the prevention of cardiovascular disease. Dr Smith has been elected to Fellow status for the American Heart Association, American College of Physicians, European Society of Cardiology, and Royal Society of Medicine. He is a Master Fellow of the American College of Cardiology. He has received the AHA’s Physician of the Year Award, Distinguished National Leadership Award, Gold Heart Award, Eugene Drake Award, Joseph Stokes Award in Preventive Cardiology, Council of Clinical Cardiology Distinguished Achievement Award, Chairman’s Award, the James Herrick Distinguished Clinician Award , and the Ron Haddock International Impact Award as well as the Brazilian Cardiology Society International Teaching Award. Dr. Smith is the recipient of the NHLBI/NIH Award of Special Recognition. Dr. Smith has authored or co-authored more than 500 published papers and chapters and has served on the editorial boards for the Journal of Cardiovascular Medicine, Journal of Clinical and Experimental Cardiology, Journal of the American College of Cardiology, Circulation and JAMA Cardiology. He is listed on Thomson Reuters list of Highly Cited Researchers, which recognizes the top 1 percent of researchers in their field and the Clarivate top 1 percent of national and international researchers. He has spoken about heart disease and stroke in interviews with CNN, CBS, and NBC, and is quoted widely by multiple national and international media. Yearly since 1998 Dr. Smith has been elected to Best Doctors in America.

Emma is a Research Fellow, NHMRC Emerging Leader and prior Heart Foundation Postdoctoral Fellow within the Centre for Health Services Research at the University of Queensland. She provides input into a range of telehealth projects across the centre. Underpinning her work more broadly is an interest in scaling-up effective interventions, monitoring the quality of their delivery and ensuring equitable provision of health services

Dr Darryn Marks PhD, MBA, M Musc (Manip), B Physio (Hons). Darryn is an Assistant Professor in Physiotherapy and Health Economics in the Institute of Evidence Based Healthcare at Bond University, supported by an NHMRC Synergy Grant SOLVE-CHD. He has membership of the Australian Physiotherapy Association, Australian Cardiac Rehabilitation Association and the Australian Health Economics Society. His main interest is in the efficient delivery of health services and his research focus is the health economic evaluation of models of care in chronic disease and advanced allied health practice. He is also the current Chair of the AHPRA Physiotherapy Board of Australia Prescribing Working Group.

A/Prof Lana McClements is a qualified Clinical Pharmacists with a PhD in Molecular Therapeutics (Queen’s University Belfast, UK). She is currently an Associate Professor and a Heart Foundation Future Fellow at the Faculty of Science, University of Technology Sydney (UTS). She leads the Cardio-Obstetrics Research group consisting of six PhD/Honours students and one Associate Lecturer/Postdoctoral Researcher. Lana’s research has been focused on developing advanced 3D bioprinted and multicellular models of placental, vascular and heart tissue towards improved monitoring and treatment of cardiovascular disease.